Assignee
PROBIOCON GMBH
CH·2 granted patents·1 pending application·0 citations·filing 2015–2020
Top patents by PatentIndex Score
3 records- 0160US12048744B2RANKL-specific agent for treating metastatic diseasePROBIOCON GMBH·Filed 2020·Granted Jul 30, 2024·0 cites·12 claims
- 0249US10806786B2RANKL-specific agent for treating metastatic diseasePROBIOCON GMBH·Filed 2015·Granted Oct 20, 2020·0 cites·16 claims
- 0333US2019218302A1Anti-cancer combination treatmentPROBIOCON GMBH·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →